en.wikipedia.org/wiki/Juno_Therapeutics

Juno Therapeutics is a biopharmaceutical company founded in 2013 through a collaboration of ... In December 2014 the company signed an agreement with Opus Bio, Inc for a chimeric antigen receptor (CAR-T) cell product candidate ...

www.geekwire.com/2018/juno-therapeutics-agrees-pay-24m-stockholders-suit-disclosure-patient-deaths

Sep 4, 2018 ... As part of the settlement, anyone who acquired Juno stock between June 4, 2016 and Nov. ... admission of wrongdoing on the part of Juno or the executives named in the lawsuit, including Bishop, Juno's current chief medical ...

www.fool.com/investing/2017/08/28/why-bluebird-bio-inc-and-juno-therapeutics-inc-sho.aspx

Aug 28, 2017 ... Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today ... is under FDA review with a decision expected on or before Nov. 29.

www.fool.com/investing/2016/06/26/better-buy-bellicum-pharmaceuticals-inc-vs-juno-th.aspx

Jun 26, 2016 ... Could the less-heralded Bellicum be the smarter pick for investors than rising star Juno Therapeutics?

www.junotherapeutics.com/work-at-juno/seattle-life

Innovation happens here Seattle is a thriving center for biomedical research and ... reflection of the region's leading role in developing pioneering medical treatments. ... Be it a shot of espresso, a pint of IPA, a glass of cabernet, or a truffle laced ...

www.junotherapeutics.com/about-us/our-values

We're on a quest to radically change the course of medicine by aligning our investments in research, manufacturing & people to change the way we treat ...

www.wsj.com/articles/celgene-to-buy-juno-therapeutics-for-9-billion-1516624153

Jan 22, 2018 ... Celgene Corp. CELG 0.19% on Monday said it agreed to buy Juno Therapeutics Inc. for $87 a share in cash, or about $9 billion, in a move that ...

www.sec.gov/Archives/edgar/data/1594864/000119312516485620/d80362d10k.htm

For the fiscal year ended December 31, 2015. OR ... Juno Therapeutics, Inc. ...... relates to an unmet medical need in a serious or life-threatening indication, ...

www.crunchbase.com/organization/juno-therapeutics

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer. ... UNO THERAPEUTICS, INC. IPO Status. Delisted.